ID

38074

Description

Two-Part Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Oral Dosesof the Enteric-Coated Free Base Formulation of Darapladib (SB-480848) ina Dose Rising Fashion and to Evaluate the Safety, Tolerability and Pharmacokinetics of Darapladib when Co-administered with Ketoconazole in Healthy Adult Subjects. There are 4 parts to this study: Screening, Part A, Part B, and Follow-Up. Part A contains 2 Sessions per day for day 1-10, Part B contains 1 Session per day for day 1-14. Each itemgroup contains information when it should be filled out. The itemgroups of the non-serious and serious adverse event forms contain additional information on the definition of a serious/non-serious adverse event.

Mots-clés

Versions (1)
  1. 15/09/2019 15/09/2019 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

15 septembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Darapladib Evaluation Case Report Form GSK LPL107988

Anglais

Investigational Product

12 Formulaires  
Administrative documentation
Description

Administrative documentation

Alias
UMLS CUI-1
C1320722
Subject Identifier
Description

Subject Identifier

Type de données

text

Alias
UMLS CUI [1]
C2348585
Visit Date
Description

Visit Date

Type de données

date

Alias
UMLS CUI [1]
C1320303
Randomisation Number
Description

Randomisation Number

Alias
UMLS CUI-1
C3897779
UMLS CUI-2
C0237753
Randomisation Number
Description

Randomisation Number

Type de données

integer

Alias
UMLS CUI [1,1]
C3897779
UMLS CUI [1,2]
C0237753
Date of Randomisation
Description

Date of Randomisation

Type de données

date

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0011008
Investigational Product Exposure
Description

Investigational Product Exposure

Alias
UMLS CUI-1
C0332157
UMLS CUI-2
C4688482
Investigational Product
Description

73 = Placebo 198 = SB-480848 (Darapladib)

Type de données

integer

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C4688482
Date and Time of Dose
Description

Date and Time of Dose

Type de données

datetime

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0178602
UMLS CUI [2,1]
C0040223
UMLS CUI [2,2]
C0178602
Dose
Description

Dose

Type de données

integer

Alias
UMLS CUI [1]
C0178602
Unit
Description

Unit

Type de données

text

Alias
UMLS CUI [1]
C0869039
Treatment Confirmation
Description

Treatment Confirmation

Alias
UMLS CUI-1
C0521091
UMLS CUI-2
C1533734
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
Description

If No, record reason(s)

Type de données

boolean

Alias
UMLS CUI [1,1]
C0521091
UMLS CUI [1,2]
C1533734
No Correct Treatment reasons
Description

No Correct Treatment reasons

Type de données

text

Alias
UMLS CUI [1,1]
C1272707
UMLS CUI [1,2]
C0205412
UMLS CUI [1,3]
C0087111
Retour au début de la page

Similar models

Investigational Product

12 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative documentation
C1320722 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Item Group
Randomisation Number
C3897779 (UMLS CUI-1)
C0237753 (UMLS CUI-2)
Randomisation Number
Item
Randomisation Number
integer
C3897779 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Date of Randomisation
Item
Date of Randomisation
date
C0034656 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Investigational Product Exposure
C0332157 (UMLS CUI-1)
C4688482 (UMLS CUI-2)
Investigational Product
Item
Investigational Product
integer
C0332157 (UMLS CUI [1,1])
C4688482 (UMLS CUI [1,2])
Date and Time of Dose
Item
Date and Time of Dose
datetime
C0011008 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0040223 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
Dose
Item
Dose
integer
C0178602 (UMLS CUI [1])
Unit
Item
Unit
text
C0869039 (UMLS CUI [1])
Item Group
Treatment Confirmation
C0521091 (UMLS CUI-1)
C1533734 (UMLS CUI-2)
Treatment Confirmation
Item
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
boolean
C0521091 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
No Correct Treatment reasons
Item
No Correct Treatment reasons
text
C1272707 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial